Fixed and adaptive beamforming improves speech perception in noise in cochlear implant recipients equipped with the MED-EL SONNET audio processor

PLoS One. 2018 Jan 5;13(1):e0190718. doi: 10.1371/journal.pone.0190718. eCollection 2018.

Abstract

Objective: To determine the impact of the fixed and adaptive beamforming technology of the new MED-EL SONNET cochlear implant audio processor on speech perception in noise.

Methods: The study cohort comprises 18 postlingually deafened adult cochlear implant recipients with at least six months of experience. Speech reception thresholds were measured with the Oldenburg Sentence Test in continuous, speech-shaped noise. Target sentences were presented in front of the listener, with noise sources placed at -135° and 135°, respectively. Outcome measures were the differences in speech reception threshold using omnidirectional, fixed and adaptive beamformer microphone settings.

Results: The use of directional microphones significantly improved speech reception thresholds: fixed beamformer vs. omnidirectional: 4.3 dB (95%-CI [3.1; 5.5]), p<0.0001; adaptive beamformer vs. omnidirectional: 6.1 dB (95%-CI [4.9; 7.3]), p<0.0001; and adaptive beamformer vs. fixed beamformer: 1.8 dB (95%-CI [0.7; 3.0]), p = 0.001.

Conclusion: This study confirms the previously reported improvements in speech perception in noise of the fixed beamformer microphone setting and is the first to report significant improvements in speech perception in noise when applying the adaptive beamformer microphone settings of the SONNET audio processor. Cochlear implant users may be able to benefit from improved hearing performance especially in difficult listening situations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aged
  • Algorithms
  • Cochlear Implants*
  • Deafness / rehabilitation*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Noise
  • Sensory Thresholds
  • Single-Blind Method
  • Speech Perception*
  • Young Adult

Grants and funding

DR and CA currently receive funding from MED-EL Corporation, Innsbruck, Austria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.